Responses
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – comorbidity and clinical aspects
FRI0137 Risk factors for major adverse cardiovascular (CV) events (MACE) in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ)
Compose a Response to This Article
Other responses
No responses have been published for this article.